Skip to content
Clinical ResearchResearch compoundModerate evidence

Hyperforin

The main antidepressant compound of St. John's wort; it indirectly blocks serotonin reuptake and can alter the effect of many drugs.

AntidepressantHerbAntidepressantMoodSerotoninDopamineNorepinephrine

Pharmacology

ClassAntidepressant · Mood
Primary targetTRPC6 channel activation, sodium influx
Targets4 receptor targets
Half-lifeApproximately 9-12 hours
OnsetAs a standardized extract with meals, typically three times daily; mood effects build over weeks
EvidenceModerate evidence
Affected systemsSerotoninDopamineNorepinephrine

Contents

DETAILED OVERVIEW

What is Hyperforin?

Hyperforin is one of the main active compounds of St. John's wort (Hypericum perforatum), regarded as a key carrier of the plant's antidepressant effect. It is not approved as a medicine on its own; St. John's wort extracts containing hyperforin are prescription antidepressants in Germany and dietary supplements or traditional herbal medicines in several countries.

It indirectly blocks the reuptake of serotonin, dopamine and norepinephrine into nerve cells. Clinical effectiveness has mainly been shown for St. John's wort extracts containing hyperforin; for hyperforin itself the evidence is mostly from laboratory and animal studies. It causes strong drug interactions: it can weaken, for example, the effect of contraceptives, blood thinners and immunosuppressants. Together with SSRI-type antidepressants it can cause serotonin syndrome, a condition caused by too much serotonin. It can also cause sensitivity to light, and its safety in pregnancy and breastfeeding has not been established.

Mechanism

TRPC6 activation, indirect monoamine reuptake inhibition

Half-life

Approximately 9-12 hours

Legal status

Herbal constituent (in St. John's Wort extract)

Receptor profile

  • TRPC6 channel / sodium influxStrong
  • Monoamine reuptake (serotonin/dopamine/norepinephrine)Moderate
  • Pregnane X receptor (CYP3A4 induction)Strong
  • BDNFWeak

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Photosensitivity (phototoxic skin reactions), especially in fair-skinned people and strong sunlight
  • Mild gastrointestinal upset, nausea, appetite changes
  • Restlessness, sleep changes and headache
  • Risk of serotonin syndrome when combined with other serotonergic drugs
  • Major drug interactions due to CYP3A4 and P-glycoprotein induction
  • Dry mouth, dizziness, occasionally skin itching

Contraindications · 5

  • Concurrent SSRI, SNRI, MAO inhibitor or triptan therapy: risk of serotonin syndrome
  • Pregnancy and breastfeeding: safety not well established, avoid
  • Patients on critical medications (contraceptives, warfarin, ciclosporin/tacrolimus, antiretroviral and anticancer drugs): enzyme induction can cause loss of efficacy
  • Before planned surgery or anesthesia: enzyme induction can alter drug metabolism
  • Known photosensitivity or concurrent photosensitizing therapy

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

As the main active compound in St. John's Wort, hyperforin is used mainly for mood support and mild-to-moderate low mood: in controlled studies, standardized St. John's Wort extracts showed effectiveness comparable to SSRI antidepressants, often with fewer people stopping treatment due to side effects. It raises levels of several brain messengers at once (serotonin, dopamine, norepinephrine), and animal studies have also found neuroprotective and anti-inflammatory effects.

Telegram

Have a question about Hyperforin?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeAntidepressant
FormulaC35H52O4
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.